These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38388289)

  • 1. The potential role of the triglyceride-glucose index in left ventricular systolic function and in-hospital outcomes for patients with acute myocardial infarction.
    Zhang C; Sun P; Li Z; Sun H; Zhao D; Liu Y; Zhou X; Yang Q
    Arch Cardiovasc Dis; 2024 Mar; 117(3):204-212. PubMed ID: 38388289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure with preserved left ventricular ejection fraction in patients with acute myocardial infarction.
    Antonelli L; Katz M; Bacal F; Makdisse MR; Correa AG; Pereira C; Franken M; Fava AN; Serrano Junior CV; Pesaro AE
    Arq Bras Cardiol; 2015 Aug; 105(2):145-50. PubMed ID: 26039659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of wall motion score index over left ventricle ejection fraction in predicting cardiovascular events after an acute myocardial infarction.
    Jurado-Román A; Agudo-Quílez P; Rubio-Alonso B; Molina J; Díaz B; García-Tejada J; Martín R; Tello R
    Eur Heart J Acute Cardiovasc Care; 2019 Feb; 8(1):78-85. PubMed ID: 27738092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial.
    Jabbar A; Ingoe L; Junejo S; Carey P; Addison C; Thomas H; Parikh JD; Austin D; Hollingsworth KG; Stocken DD; Pearce SHS; Greenwood JP; Zaman A; Razvi S
    JAMA; 2020 Jul; 324(3):249-258. PubMed ID: 32692386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular obstruction extent predicts major adverse cardiovascular events in patients with acute myocardial infarction and preserved ejection fraction.
    Galea N; Dacquino GM; Ammendola RM; Coco S; Agati L; De Luca L; Carbone I; Fedele F; Catalano C; Francone M
    Eur Radiol; 2019 May; 29(5):2369-2377. PubMed ID: 30552479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular magnetic resonance-derived left atrioventricular coupling index and major adverse cardiac events in patients following acute myocardial infarction.
    Lange T; Backhaus SJ; Schulz A; Evertz R; Kowallick JT; Bigalke B; Hasenfuß G; Thiele H; Stiermaier T; Eitel I; Schuster A
    J Cardiovasc Magn Reson; 2023 Apr; 25(1):24. PubMed ID: 37046343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-blockers in patients without heart failure after myocardial infarction.
    Safi S; Sethi NJ; Korang SK; Nielsen EE; Feinberg J; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012565. PubMed ID: 34739733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocker prescription and outcomes in uncomplicated acute myocardial infarction: Insight from the ePARIS registry.
    Suc G; Zeitouni M; Procopi N; Guedeney P; Kerneis M; Barthelemy O; Le Feuvre C; Helft G; Rouanet S; Brugier D; Collet JP; Vicaut E; Montalescot G; Silvain J
    Arch Cardiovasc Dis; 2023 Jan; 116(1):25-32. PubMed ID: 36549972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.
    Huang L; Zhang J; Huang Q; Cui R; Chen J
    BMC Cardiovasc Disord; 2023 Apr; 23(1):198. PubMed ID: 37069503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empagliflozin and colchicine in patients with reduced left ventricular ejection fraction following ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: a study protocol for a randomized, double-blinded, three-arm parallel-group, controlled trial.
    Khiali S; Taban-Sadeghi M; Sarbakhsh P; Khezerlouy-Aghdam N; Namdar H; Salehi R; Rezagholizadeh A; Entezari-Maleki T
    Trials; 2023 Oct; 24(1):645. PubMed ID: 37803449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: the Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study.
    Bloch Thomsen PE; Jons C; Raatikainen MJ; Moerch Joergensen R; Hartikainen J; Virtanen V; Boland J; Anttonen O; Gang UJ; Hoest N; Boersma LV; Platou ES; Becker D; Messier MD; Huikuri HV;
    Circulation; 2010 Sep; 122(13):1258-64. PubMed ID: 20837897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular ejection fraction assessment among patients with acute myocardial infarction and its association with hospital quality of care and evidence-based therapy use.
    Miller AL; Dib C; Li L; Chen AY; Amsterdam E; Funk M; Saucedo JF; Wang TY
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):662-71. PubMed ID: 22949495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
    Otterstad JE; St John Sutton MG; Froeland GS; Holme I; Skjaerpe T; Hall C
    Eur Heart J; 2002 Jul; 23(13):1011-20. PubMed ID: 12093053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic determinants of left ventricular ejection fraction after acute myocardial infarction.
    McClements BM; Weyman AE; Newell JB; Picard MH
    Am Heart J; 2000 Aug; 140(2):284-9. PubMed ID: 10925344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum cardiac troponin T in patients with acute myocardial infarction. Detection of coronary reperfusion and prediction of cardiac function.
    Kitaoka H; Miyazaki S; Nonogi H; Furuno T; Itoh A; Daikoku S; Nakao K; Yamamoto Y; Haze K
    Jpn Heart J; 1995 May; 36(3):293-303. PubMed ID: 7650837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systolic left ventricular function after reperfusion therapy for acute myocardial infarction. Analysis of determinants of improvement. The TAMI Study Group.
    Harrison JK; Califf RM; Woodlief LH; Kereiakes D; George BS; Stack RS; Ellis SG; Lee KL; O'Neill W; Topol EJ
    Circulation; 1993 May; 87(5):1531-41. PubMed ID: 8491008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Magnetic Resonance Left Ventricular Mechanical Uniformity Alterations for Risk Assessment After Acute Myocardial Infarction.
    Stiermaier T; Backhaus SJ; Lange T; Koschalka A; Navarra JL; Boom P; Lamata P; Kowallick JT; Lotz J; Gutberlet M; de Waha-Thiele S; Desch S; Hasenfuß G; Thiele H; Eitel I; Schuster A
    J Am Heart Assoc; 2019 Aug; 8(16):e011576. PubMed ID: 31387432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different prognostic factors according to left ventricular systolic function in patients with acute myocardial infarction.
    Im MS; Kim HL; Kim SH; Lim WH; Seo JB; Chung WY; Zo JH; Kim MA; Park KW; Koo BK; Kim HS; Chae IH; Cho DJ; Ahn Y; Jeong MH;
    Int J Cardiol; 2016 Oct; 221():90-6. PubMed ID: 27400303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined assessment of left ventricular end-diastolic pressure and ejection fraction by left ventriculography predicts long-term outcomes of patients with ST-segment elevation myocardial infarction.
    Saito D; Nakanishi R; Watanabe I; Yabe T; Okubo R; Amano H; Toda M; Ikeda T
    Heart Vessels; 2018 May; 33(5):453-461. PubMed ID: 29143103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of the left ventricular global function index in predicting major adverse cardiovascular events in acute coronary syndrome patients.
    Doganay B; Celebi OO
    Biomark Med; 2023 Jan; 17(1):5-16. PubMed ID: 36942625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.